Search Results - "Babenko A, Yu"

Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis by Babenko, A. Yu, Vasilyeva, E. Yu, Lyasnikova, E. A., Lebedev, D. A., Shlyakhto, E. V.

“…As myocardial fibrosis might be an important contributor to the association of diabetes mellitus with left ventricular (LV) dysfunction and chronic heart…”
Get full text

Multimodal Optical Diagnostics of Glycated Biological Tissues by Smolyanskaya, O. A., Lazareva, E. N., Nalegaev, S. S., Petrov, N. V., Zaytsev, K. I., Timoshina, P. A., Tuchina, D. K., Toropova, Ya. G., Kornyushin, O. V., Babenko, A. Yu, Guillet, J.-P., Tuchin, V. V.

“…Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia accompanied by the disruption of carbohydrate, lipid, and proteins metabolism…”
Get full text

Metformin in prediabetes: key mechanisms for the prevention of diabetes and cardiometabolic risks by Babenko, A. Yu

“…Today, prediabetes is regarded by the world medical community as early diabetes mellitus. The accumulated research evidence shows that prediabetes is…”
Get full text

Imbalance of Hormones Involved in Energy Balance Regulation in Obese Patients: a Study of Its Relationship with Disturbed Eating Behavior and Abnormal Metabolic Parameters by Babenko, A. Yu, Matveev, G. A.

“…In healthy people, postprandial status is characterized by a particular dynamics of the level of hormones involved in the regulation of eating behavior and…”
Get full text

Efficacy of sibutramine in different types of eating behavior in obese patients by Matveev, G. A., Babenko, A. Yu

“…Introduction. One of the key factors contributing to the development and progression of obesity is impairment eating behavior (EB). Therefore, drug therapy for…”
Get full text

The daily dose of testosterone-replacement therapy dependence from the body mass index in FtM transgender PATIENTS by Sergeeva, L. Y., Babenko, A. Yu

“…BACKGROUND : The basis for the management of transgender patients is the use of various hormonal correction schemes necessary for changing the hormonal sex…”
Get full text

Problems of blood glucose self-monitoring in patients with diabetes mellitus by Kononova, Yu. A., Bregovskiy, V. B., Babenko, A. Yu

“…Glycemic self-monitoring is essential in  the  treatment of  diabetes mellitus. Compliance with the  recommendations for  selfmonitoring of glycemia is an…”
Get full text

Fibrosis biomarkers and echocardiographic parameters in patients with type 2 diabetes depending on the degree of albuminuria by Lebedev, D. A., Laevskaya, M. Yu, Babenko, A. Yu

“…Background. Diabetic nephropathy (DN) in patients with type 2 diabetes mellitus (T2DM) is associated with a risk of developing chronic heart failure (CHF). The…”
Get full text

Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor by Lebedev, D. A., Mosikian, A. A., Babenko, A. Yu

“…Despite the emergence of new groups of drugs for the treatment of type 2 diabetes mellitus (DM2), the issue of optimal adherence to treatment remains of…”
Get full text

Glucagon-like peptide-1 receptor agonists, selection within the class. The rational combination of insulin glargine 100 + lixisenatide by Martjanova, M. V., Babenko, A. Yu

“…Type 2 diabetes mellitus (T2DM) is a progressive disease accompanied by a gradual worsening of β-cell function. With a long course of T2DM, a significant…”
Get full text

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes by Lebedev, D. A., Lyasnikova, E. A., Vasilyeva, A. A., Vasilyeva, E. Yu, Babenko, A. Yu, Shlyakhto, E. V.

“…Aim. To study molecular biomarkers in patients with type 2 diabetes (T2D) in combination with heart failure with preserved (HFpEF) and mid-range ejection…”
Get full text

Ratio of Perfusion in the Skin of the Index Finger and Big Toe in Patients with Type 2 Diabetes Mellitus by Glazkov, A. A., Glazkova, P. A., Kovaleva, Yu. A., Babenko, A. Yu, Kononova, Yu. A., Kitaeva, E. A., Kulikov, D. A., Lapitan, D. G., Rogatkin, D. A.

“…The aim of this study was to investigate the ratio of baseline perfusion levels in the skin of the palmar surfaces of the fingers and plantar surfaces of the…”
Get full text

Biomarkers associated with atherogenesis: current status and promising areas by Magruk, M. A., Mosikyan, A. A., Babenko, A. Yu

“…Biomarkers being used as a laboratory test allow diagnosing the disease at an early stage, confirming diagnostic assumptions or evaluating treatment results…”
Get full text

Evaluation eff ects of IDPP4 therapy diff erent duration on the functional state of α- and β- cells in patients with type 2 diabetes mellitus by Tuchina, T. P., Kolchanova, I. A., Meltonyan, A. R., Abramyan, L. K., Babenko, A. Yu, Galagudza, M. M.

“…Purpose: evaluate the eff ects of DPP4i on fasting and postprandial insulin and glucagon secretion by examining basal secretion and response to food loading…”
Get full text

Use of sodium-glucose co-transporter-2 inhibitors from clinical trial results to practical application in Russia by D. A. Lebedev, A. Yu. Babenko

“…In clinical trials of drugs, including sodium-glucose co-transporter-2 inhibitors (SGLT2), the main reason for the discontinuation of the therapy are side…”
Get full text

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions by Lyasnikova, E. A., Kuular, A. A., Pavlovskaya, A. V., Vlasenko, A. N., Kozlenok, A. V., Babenko, A. Yu, Sitnikova, M. Yu, Shlyakhto, E. V.

“…Aim . To analyze and compare the clinical, echocardiographic characteristics and serum N-terminal pro-brain natriuretic peptide (NT-proBNP) levels depending on…”
Get full text

Effects of Bariatric Surgeries on the Size of Myocardial Infarction and Ghrelin Level in Rats with Experimental Decompensated Type 2 Diabetes Mellitus by Kornyushin, O. V., Sonin, D. L., Toropova, Ya. G., Pochkaeva, E. I., Semikova, G. V., Berko, O. M., Zelinskaya, I. A., Todosenko, N. M., Litvinova, L. S., Neimark, A. E., Babenko, A. Yu, Dergach, K. V., Schpakov, A. O., Galagudza, M. M.

“…The effects of bariatric surgeries (sleeve gastrectomy and ileal transposition) on the dynamics of changes in ghrelin level were studied in rats with severe…”
Get full text

GLYCEMIC AND NON-GLYCEMIC EFFECTS OF EXENATIDE IN PATIENTS WITH DIABETES MELLITUS OF TYPE 2 (DM2) WITH MYOCARDIAL INFARCTION by A. Yu. BABENKO, V. A. ZYKOV, E. N. GRINEVA

“…It is known that at DM2 is raised considerably risk of development of myocardial infarction (MI) and mortality from it. For decrease these risk it is important…”
Get full text

Polymorphism of S19W of apolipoprotein A5gene in patients with type 2 diabetes mellitus - connection with metabolic parameters and triglyceride levels by Skoryukova, S. A., Kim, M. V., Bystrova, A. A., Babenko, A. Yu, Baranova, E. I., Pchelina, S. N.

“…The article deals with genetic aspects of the influence of S19W polymorphic variants of apolipoprotein A5 gene, on the blood lipids in patients with type 2…”
Get full text

THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES by Shestakova, M. V., Boytsov, S. A., Drapkina, O. M., Demidova, T. Yu, Drexel, H., Antsiferov, M. B., Petunina, N. A., Chernikova, N. A., Kalashnikov, V. Yu, Bardymova, T. P., Protasov, V. K., Babenko, A. Yu, Ruyatkina, L. A., Klimontov, V. V., Salukhov, V. V., Fadeev, V. V., Karpov, Yu. A.

“…The interdisciplinary interim experts’ council on March 3, 2016 in Moscow have considered the EMPA-REG OUTCOME trial results and suggested a number of…”
Get full text